GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Procter & Gamble Health Ltd

P&G Health Q2 FY27 Net Profit ₹11,151 Lakhs; Revenue ₹38,249 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Nov 2026, 02:43 PM IST  ·  BSE ID: c5643bfa-8057-47cc-b18f-544b97ff3c12
View Original BSE Filing (PDF)
💡
In Simple Terms
Procter & Gamble Health reported its financial results for the quarter, showing a net profit of ₹11,151 Lakhs.
🤖 AI Summary
  • Procter & Gamble Health reported a net profit of ₹11,151 Lakhs for Q2 FY27.
  • Revenue from operations for the quarter ended September 30, 2026, was ₹38,249 Lakhs.
  • Six-month net profit (April 1 to September 30, 2026) reached ₹20,766 Lakhs.
  • Total income for the six months was ₹75,397 Lakhs, with basic and diluted EPS of ₹125.09.
  • The Board of Directors approved the unaudited financial results on November 2, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
₹38,249 Lakhs
17.72%
Net Profit for the Period (Q2 FY27)
₹11,151 Lakhs
1.67%
Total Income (Six months ended Sept 30, 2026)
₹75,397 Lakhs
13.06%
Net Profit for the Period (Six months ended Sept 30, 2026)
₹20,766 Lakhs
34.28%
Basic and Diluted EPS (Q2 FY27, after exceptional items)
₹67.18
26.01%
🏢 How This Affects the Company
📈
Business Impact
The company's revenue from operations increased to ₹38,249 Lakhs in Q2 FY27 compared to ₹32,492 Lakhs in the corresponding Q2 FY26, indicating continued sales growth.
💰
Financial Impact
Net profit for Q2 FY27 was ₹11,151 Lakhs, a rise from ₹10,968 Lakhs in the corresponding prior year quarter. Total equity increased to ₹65,805 Lakhs as of September 30, 2026, from ₹52,455 Lakhs as of March 31, 2026.
⚙️
Operational Impact
Cost of materials consumed for the six months ended September 30, 2026, was ₹15,200 Lakhs, compared to ₹13,767 Lakhs in the corresponding prior period, reflecting higher production or sales volumes.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, with Basic and Diluted EPS (after exceptional items) reported at ₹67.18 for the quarter.
🔍
Management Signal
The approval and disclosure of unaudited financial results signals management's adherence to regulatory compliance and commitment to transparency regarding company performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — review revenue and profit trends.
Annual General Meeting (AGM) date — monitor any new resolutions.
Updates on segment-wise performance — if provided in future filings.
LOW RISK The filing reports routine financial results with no material adverse statements or auditor qualifications.
💡 Investor Takeaway
Procter & Gamble Health reported Q2 FY27 net profit at ₹11,151 Lakhs, a 1.67% increase from ₹10,968 Lakhs in Q2 FY26. Revenue from operations for the quarter was ₹38,249 Lakhs, up 17.72% YoY. Six-month net profit stood at ₹20,766 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Net Profit for Q2 FY27 increased to ₹11,151 Lakhs from ₹10,968 Lakhs in Q2 FY26, representing a 1.67% increase.
  • Revenue from Operations for Q2 FY27 grew to ₹38,249 Lakhs, up 17.72% from ₹32,492 Lakhs in Q2 FY26.
📅 Company Track Record
In Q1 FY27 (quarter ended June 30, 2026), Procter & Gamble Health reported sales of ₹35,600 Lakhs and a reported PAT of ₹9,615 Lakhs. The Q1 PAT was aided by a ₹3,180 Lakhs property sale gain. Q2 FY27 results show a slight increase in net profit over Q1 FY27 (excluding the exceptional item).

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Procter & Gamble Health's net profit in Q2 FY27?
Procter & Gamble Health reported a net profit of ₹11,151 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the revenue from operations for Procter & Gamble Health in Q2 FY27?
The revenue from operations for Procter & Gamble Health for Q2 FY27 was ₹38,249 Lakhs.
What were the six-month financial results for Procter & Gamble Health up to September 30, 2026?
For the six months from April 1, 2026, to September 30, 2026, Procter & Gamble Health reported a net profit of ₹20,766 Lakhs and total income of ₹75,397 Lakhs.
What is the Basic and Diluted EPS for Procter & Gamble Health for Q2 FY27?
The Basic and Diluted Earnings Per Share (after exceptional items) for Procter & Gamble Health for Q2 FY27 was ₹67.18.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.